Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UK-369,003 in erectile dysfunction
NCT00141349Phase 2Completed
- Sponsor
- Pfizer
- Start
- Feb 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in erectile dysfunction (ED) comparing Placebo with UK-369,003 (2 arms). Primary endpoint: The time needed to obtain an erection hard enough to attempt sexual intercourse. Started Feb 2005; status: completed.
02
Drugs
gisadenafil besylate
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on NCT00141349.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00141349.